Continuing the Conversation: Overcoming Lung Cancer Stigma

Continuing the Conversation: Overcoming Lung Cancer Stigma

The latest episode of Lung Cancer Considered brings you part two of our conversation on lung cancer stigma during Lung Cancer Awareness Month. This episode features a discussion with Jill Feldman, patient advocate; Terri Conneran, a three-time lung cancer survivor and advocate and director and founder of KRAS Kickers and the director of LiveLung International Relations; Jamie L. Studts, a professor in the division of medical oncology, department of medicine at the University of Colorado School of Medicine; and Mary Pasquinelli, a nurse practitioner in the Pulmonary Division at UI Health at the University of Illinois.

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(399)

LCC: Grace Under Pressure: Navigating Burnout and Loss in Oncology

LCC: Grace Under Pressure: Navigating Burnout and Loss in Oncology

In this episode of Lung Cancer Considered, host Dr. Narjust Florez is joined by Dr. Mark Lewis and Dr. Michael Maddaus for a candid conversation about physician wellness, burnout, grief, and resilienc...

18 Aug 47min

LCC Advances in ALK+ Cancer in Cantonese

LCC Advances in ALK+ Cancer in Cantonese

As part of IASLC’s ongoing series of Lung Cancer Considered podcasts in world languages, Dr. Molly Li moderates a discussion in Cantonese with Dr. Tony Mok, Dr. Chao Zhang, and Dr. Wen-Zhao Zhong. The...

14 Aug 46min

Treating Advanced Thymic Cancers

Treating Advanced Thymic Cancers

Thymic epithelial tumors are rare but complex thoracic cancers that require specialized diagnosis and multidisciplinary management. In this episode of Lung Cancer Considered, Dr. Stephen Liu is joined...

4 Aug 59min

FDA Approval: Zidesamtinib and ROS1 NSCLC

FDA Approval: Zidesamtinib and ROS1 NSCLC

Patients with ROS1-positive NSCLC have a new treatment option following the FDA approval of zidesamtinib for those previously treated with a ROS1 tyrosine kinase inhibitor. In this episode, Dr. Stephe...

28 Jul 24min

Rewriting the Playbook: Cellular Therapy and Vaccines for ALK-Positive Lung Cancer

Rewriting the Playbook: Cellular Therapy and Vaccines for ALK-Positive Lung Cancer

How could cellular therapies and cancer vaccines transform the future of treatment for ALK-positive lung cancer? Host Dr. Narjust Florez sits down with Dr. Vincent Lam and Dr. Carmen Mecca to explore ...

21 Jul 47min

IASLC - Your First Faculty Job

IASLC - Your First Faculty Job

Starting your first faculty position can be both exciting and overwhelming. In this episode of Lung Cancer Considered, host Dr. Narjust Florez is joined by Dr. Arthi Sridhar to discuss the transition ...

7 Jul 41min

Game Changers & Hard Truths: Dr. Balazs Halmos Unfiltered

Game Changers & Hard Truths: Dr. Balazs Halmos Unfiltered

In this episode of Lung Cancer Considered, Dr. Balazs Halmos reflects on a career at the forefront of thoracic oncology, sharing the pivotal moments, lessons learned, and hard truths that have shaped ...

23 Jun 45min

Welcome to Seoul: 2026 World Conference on Lung Cancer (WCLC) Preview

Welcome to Seoul: 2026 World Conference on Lung Cancer (WCLC) Preview

This episode of Lung Cancer Considered provide a preview of the upcoming IASLC 2026 World Conference on Lung Cancer in Seoul, South Korea this September. Key topics covered include WCLC26 highlights -...

12 Jun 39min

Populært innen Vitenskap

fastlegen
tingenes-tilstand
rss-nysgjerrige-norge
romkapsel
liberal-halvtime
rekommandert
rss-paradigmepodden
tomprat-med-gunnar-tjomlid
jss
sinnsyn
smart-forklart
fjellsportpodden
villmarksliv
forskningno
vett-og-vitenskap-med-gaute-einevoll
rss-rekommandert
diagnose
rss-inn-til-kjernen-med-sunniva-rose
abels-tarn
dekodet-2